Rakic, D.; Jakovljevic, V.; Jovic, N.; Bicanin Ilic, M.; Dimitrijevic, A.; Vulovic, T.; Arsenijevic, P.; Sretenovic, J.; Nikolic, M.; Petrovich Fisenko, V.;
et al. The Potential of SGLT-2 Inhibitors in the Treatment of Polycystic Ovary Syndrome: The Current Status and Future Perspectives. Biomedicines 2023, 11, 998.
https://doi.org/10.3390/biomedicines11040998
AMA Style
Rakic D, Jakovljevic V, Jovic N, Bicanin Ilic M, Dimitrijevic A, Vulovic T, Arsenijevic P, Sretenovic J, Nikolic M, Petrovich Fisenko V,
et al. The Potential of SGLT-2 Inhibitors in the Treatment of Polycystic Ovary Syndrome: The Current Status and Future Perspectives. Biomedicines. 2023; 11(4):998.
https://doi.org/10.3390/biomedicines11040998
Chicago/Turabian Style
Rakic, Dejana, Vladimir Jakovljevic, Nikola Jovic, Marija Bicanin Ilic, Aleksandra Dimitrijevic, Tatjana Vulovic, Petar Arsenijevic, Jasmina Sretenovic, Maja Nikolic, Vladimir Petrovich Fisenko,
and et al. 2023. "The Potential of SGLT-2 Inhibitors in the Treatment of Polycystic Ovary Syndrome: The Current Status and Future Perspectives" Biomedicines 11, no. 4: 998.
https://doi.org/10.3390/biomedicines11040998
APA Style
Rakic, D., Jakovljevic, V., Jovic, N., Bicanin Ilic, M., Dimitrijevic, A., Vulovic, T., Arsenijevic, P., Sretenovic, J., Nikolic, M., Petrovich Fisenko, V., Bolevich, S., Zarkovic, G., & Joksimovic Jovic, J.
(2023). The Potential of SGLT-2 Inhibitors in the Treatment of Polycystic Ovary Syndrome: The Current Status and Future Perspectives. Biomedicines, 11(4), 998.
https://doi.org/10.3390/biomedicines11040998